Coverage dated October 21, 2026

BCG Vaccine-Induced Trained Immunity May Help Protect Against Dementia

Headline from Geneng News

The results of a preclinical study suggest that the BCG vaccine, which is widely used to prevent tuberculosis and treat bladder cancer, may also have properties that reduce the risk for dementia by inducing trained immunity.

Geneng News's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

2 articles, oldest first.

MedicalXpress
Tuberculosis vaccine's link to reduced dementia risk gains mechanistic support (opens MedicalXpress)
Published Oct 21, 2026
MedicalXpress's feed description
Bacillus Calmette-Guerin (BCG), a vaccine widely used to prevent tuberculosis and treat bladder cancer, may also have properties that reduce the risk for dementia, according to new findings in a study of mice.
Geneng News
BCG Vaccine-Induced Trained Immunity May Help Protect Against Dementia (opens Geneng News)
Published Oct 21, 2026
Geneng News's feed description
The results of a preclinical study suggest that the BCG vaccine, which is widely used to prevent tuberculosis and treat bladder cancer, may also have properties that reduce the risk for dementia by inducing trained immunity.